Client Consultation, Skin Analysis and Treatment Planning
What this domain tests
This domain tests structured consultation, informed consent, skin analysis, contraindication screening, lesion recognition and defensible treatment planning.
Core rules and concepts
- Obtain informed consent before touching the client or performing a test patch; explain benefits, risks, alternatives and aftercare.
- Record medical history, medicines, allergies, pregnancy or breastfeeding, recent cosmetic procedures, sun exposure and product use.
- Skin analysis uses cleansing, visual inspection, palpation, a magnifying lamp and good lighting; note lesions, erythema, dehydration, oiliness, texture and scarring.
- Use ABCDE for pigmented lesions: Asymmetry, Border irregularity, Colour variation, Diameter greater than 6 mm, Evolving. Refer suspicious lesions; do not treat.
- Fitzpatrick phototype guides UV risk; skin type such as dry, oily or combination is not the same as skin condition.
- Contraindications include active infection, open wounds, uncontrolled eczema or psoriasis, recent isotretinoin, photosensitising medication, allergy to ingredients and unrealistic expectations.
- Treatment plan: goals, modality, frequency, home care, review date and referral triggers.
Worked example
A 24-year-old requests a facial peel but has started isotretinoin. Reasoning: isotretinoin increases fragility and reduces healing; resurfacing and waxing are typically avoided during treatment and for a period after, following current guidance and insurer policy. Offer gentle barrier support and review after discontinuation with medical advice; document the refusal and referral.
Traps that cost marks
- Treating a changing mole as a cosmetic blemish.
- Assuming one consent covers all future treatments.
- Confusing skin type with skin condition.
- Missing photosensitising medication.
- Writing vague plans such as facial as needed.